Hyemin Kim Selected Research

Hyemin Kim Research Topics

Disease

18	Neoplasms (Cancer) 02/2022 - 03/2011
6	Inflammation (Inflammations) 03/2016 - 07/2012
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2011
4	Infections 03/2016 - 11/2011
3	Adenocarcinoma 02/2022 - 11/2016
3	Fibrosis (Cirrhosis) 10/2021 - 01/2013
3	Liver Diseases (Liver Disease) 08/2021 - 07/2011
3	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2016
3	Wounds and Injuries (Trauma) 11/2019 - 11/2016
3	Rheumatoid Arthritis 01/2017 - 07/2012
3	Pneumonia (Pneumonitis) 03/2016 - 11/2013
2	Circulating Neoplastic Cells 02/2022 - 01/2020
2	Hemolysis 08/2021 - 08/2021
2	Drug-Related Side Effects and Adverse Reactions 11/2019 - 01/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 03/2016 - 11/2011
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015 - 01/2015
2	Asthma (Bronchial Asthma) 12/2015 - 11/2013
2	Melanoma (Melanoma, Malignant) 10/2015 - 03/2011
2	Colonic Neoplasms (Colon Cancer) 06/2015 - 01/2015
2	Corneal Neovascularization 01/2015 - 11/2012
2	Weight Loss (Weight Reduction) 12/2013 - 02/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2012 - 04/2011
1	Disease Progression 02/2022
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 03/2021
1	Experimental Melanoma 10/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 09/2019
1	Osteoporosis 05/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2017
1	Myocardial Infarction 10/2016
1	Sarcoma (Soft Tissue Sarcoma) 03/2016
1	Muscular Dystrophies (Muscular Dystrophy) 03/2016
1	Human Influenza (Influenza) 03/2016
1	Muscular Diseases (Myopathy) 03/2016
1	Shock 02/2016
1	Combined Pituitary Hormone Deficiency 01/2016

Drug/Important Bio-Agent (IBA)

10	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2016 - 03/2011
9	Peptides (Polypeptides)IBA 10/2019 - 04/2011
6	CytokinesIBA 11/2016 - 01/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 07/2011
5	Therapeutic UsesIBA 10/2019 - 11/2013
4	Hyaluronic Acid (Hyaluronan)IBA 05/2018 - 11/2011
4	AlloferonIBA 12/2015 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2019
3	EnzymesIBA 08/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 08/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 07/2012
2	Epidermal Growth Factor (EGF)IBA 05/2018 - 11/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2016 - 12/2015
2	InterferonsIBA 09/2015 - 04/2013
2	MicellesIBA 01/2015 - 11/2012
2	LigandsIBA 01/2015 - 01/2013
2	Retinaldehyde (Retinal)IBA 11/2012 - 04/2011
1	FilaminsIBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2022
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 01/2022
1	EndotoxinsIBA 08/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2021
1	CholesterolIBA 03/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2021
1	Adenosine Triphosphate (ATP)IBA 03/2021
1	EpitopesIBA 10/2019
1	AntigensIBA 10/2019
1	UridineIBA 10/2019
1	TransferasesIBA 10/2019
1	FGLL peptideIBA 10/2019
1	Pulsatilla saponin DIBA 09/2019
1	SaponinsIBA 09/2019
1	Temozolomide (Temodar)FDA LinkGeneric 09/2019
1	CaspasesIBA 09/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	CalponinsIBA 01/2019
1	UbiquitinIBA 01/2019
1	Parathyroid Hormone (Parathormone)IBA 05/2018
1	CalciumIBA 05/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2018
1	Teriparatide (Parathar)FDA Link 05/2018
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Gemcitabine FDA Link 11/2016
1	Cancer VaccinesIBA 11/2016
1	MicroRNAs (MicroRNA)IBA 10/2016
1	MyostatinIBA 03/2016

Therapy/Procedure

7	Therapeutics 10/2019 - 04/2011
3	Aftercare (After-Treatment) 01/2016 - 04/2011
2	Drug Therapy (Chemotherapy) 02/2022 - 06/2021
2	Lasers (Laser) 10/2015 - 04/2011
1	Immunotherapy 10/2019
1	Subcutaneous Injections 05/2018
1	Enzyme Therapy 01/2017
1	Bioreactors (Bioreactor) 02/2016
1	Radiotherapy 01/2016